{"id":"W2023584100","doi":"10.2174/1381612023393099","title":"The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives","year":2002,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University","funders":"","keywords":"Clinical trial; Clinical study design; Medicine; Clinical endpoint; Discontinuation; Endpoint Determination; Medical physics; Drug development; Randomized controlled trial; Surrogate endpoint; Computer science; Pharmacology; Internal medicine; Drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05131042,0.001105992,0.009310959,0.000163774,0.0002302774,0.0002625822,0.001272586,0.000920734,0.0001577635],"category_scores_gemma":[0.4283848,0.0006665454,0.002171192,0.0005288839,0.001351309,0.0001279049,0.0002958461,0.001924135,0.0000283125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006847044,"about_ca_system_score_gemma":0.001416693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":3.902739e-7,"about_ca_topic_score_gemma":3.348864e-8,"domain_scores_codex":[0.9449779,0.0416692,0.01001144,0.001354837,0.0009747563,0.001011857],"domain_scores_gemma":[0.4404253,0.5532321,0.0038756,0.0008687723,0.0003503358,0.001247888],"domain_codex":null,"domain_gemma":"methods","domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005622144,0.0004915161,6.124037e-7,0.008543742,0.001199576,0.000005674944,0.00002703002,2.787118e-7,7.446687e-7,0.0305075,0.03672871,0.9219324],"study_design_scores_gemma":[0.003539449,0.0007093897,5.379177e-7,0.006969236,0.007753438,0.000008725478,0.000003917734,0.001597499,0.00002900766,0.3407529,0.6379958,0.0006401347],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.332564e-8,0.5009511,0.4904962,0.0000937501,0.001561278,0.006674996,0.0001396553,0.00006020402,0.00002274273],"genre_scores_gemma":[3.467642e-7,0.561427,0.436731,0.0000267271,0.001244063,0.0003943521,0.000007849749,0.0001060972,0.00006251367],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9212922,"threshold_uncertainty_score":0.9995786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.9702097865430614,"score_gpt":0.7440994896269888,"score_spread":0.2261102969160727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}